# Effects of Intracoronary Prourokinase on the Coronary Flow During Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction

> **NCT02131220** · PHASE4 · COMPLETED · sponsor: **Fudan University** · enrollment: 362 (actual)

## Conditions studied

- Myocardial Infarction
- Percutaneous Coronary Intervention
- Thrombolytic Therapy

## Interventions

- **DRUG:** Prourokinase
- **DRUG:** Tirofiban
- **DRUG:** normal saline

## Key facts

- **NCT ID:** NCT02131220
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11
- **Primary completion:** 2017-08
- **Final completion:** 2017-09
- **Target enrollment:** 362 (ACTUAL)
- **Last updated:** 2018-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02131220

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02131220, "Effects of Intracoronary Prourokinase on the Coronary Flow During Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02131220. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*